Abstract
TGR5 is the first bile acid sensing G-protein coupled bile acid receptor (GPCR) GPCR and directly interacts with several G-protein subtypes [1]. High expression levels of TGR5 are found in the brain, the liver, and the gastrointestinal tract. TGR5 is an emerging target for the treatment of metabolic diseases [2 – 4]. Therefore, developing selective and potent agonists of TGR5 is of high importance [5]. However, without an x-ray crystal structure or an experimentally determined binding mode, the rational design of compounds is difficult.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
